Oncology Devices Market Report

Oncology Devices Market Analysis, Market Size, Application Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2014 To 2020

Format: PDF  |  Report ID: GVR1105

Oncology devices market is expected to grow during the forecast period owing to the increasing prevalence of cancer globally and healthcare expenditure level of the patients. According to W.H.O, cancer accounted for approximately 8.2 million deaths worldwide in 2013. However, stringency in regulatory policies related to medical devices is expected to impede growth of oncology devices market. 

Oncology devices market can be studied with respect to two broad segments based on diagnosis and therapeutics. The therapeutic segment is divided into chemotherapy, hormone therapy, biotherapy and radiation therapy. Diagnosis segment is sub segmented in to biopsy, imaging, endoscopy and blood tests. Endoscopy segment is identified to be one of the major revenue generating segments owing to the benefits such as minimally invasive and cost effective in nature.  Operative endoscopy devices are expected to be one of the fastest growing segments. Biotherapy or biotech drugs are gaining popularity owing to its effectiveness. Radiation therapy was identified as one of the major markets in 2013 owing to the greater usage rate. Similarly, chemotherapy is also expected to exhibit a notable growth in the forecast period. Early detection of cancer can be instrumental in reducing cancer fatalities, hence R&D is going on to develop devices and technologies which would be helpful in early prognosis of cancer. 

Geographically, oncology devices market is studied with respect to four regions such as North America, Europe, Asia Pacific and RoW. Higher prevalence rate of cancer along with advanced healthcare infrastructure and supportive reimbursement policies have helped North America to be most mature market in 2013. European market is expected to follow North American market. Asia pacific oncology devices market is expected to be the most lucrative market owing to increasing penetration, untapped opportunity,  increasing patient & healthcare professionals awareness levels and rapidly improvising healthcare infrastructure in emerging economies such as China & India. 

The oncology devices market has few prominent players investing majorly on R&D. Prominent players studied in this market include  Accuray, GE healthcare, Oncura Inc, Eckert and Ziegler Bebig, IBA group, PLC, Biogenex Laboratories Varian Medical Systems, C.R Bard Inc., Roche diagnostics, Elekta AB, and Theragenics Corporation.

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $4,950
Multi User - $5,950
Library Access - $7,950

Buy Chapters or Sections

Avail customized purchase options to meet your research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Custom research service

    Custom research service

    Speak to the report author to design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service excellence represented in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • BOA